CEACAM5 and neoplasm: The proposed system was used for detecting tumor biomarkers such as alpha fetoprotein (AFP) and carcinoembryonic antigen (CEA) and the bacterial infection biomarker procalcitonin (PCT) in serum samples and in whole blood.